Hypertension management in chronic kidney disease: insights from a multicenter survey of nephrologists in India
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20253765Keywords:
Hypertension, Chronic kidney disease, Nephrologist, Calcium channel blockers, Real-world surveyAbstract
Background: Due to inadequate treatment adherence, delayed diagnosis, and a lack of healthcare resources, managing hypertension (HT) in patients with chronic kidney disease (CKD) in many regions of India is really difficult. This survey looks at ways to improve care through lifestyle changes, guideline-based interventions, and evidence-based practices.
Methods: "A cross-sectional, structured, multicenter survey of 304 nephrologists across India was conducted from August to November 2024. A questionnaire was developed to gather valuable insights into their clinical practices and preferences concerning the diagnosis and management of HT in CKD patients.
Results: Personalized approaches utilizing ACE inhibitors, ARBs, and CCBs for renal and cardiovascular benefits are necessary for the effective management of HT in CKD. Preventing the progression of CKD requires addressing non-adherence and enhancing patient education. Although they reduced proteinuria, combination treatments involving ACE inhibitors and ARBs raised safety questions. Nephrologists highlighted the clinical benefits of using specific medications in patients with CKD, especially for their effectiveness in managing related comorbidities and slowing the progression of the disease, despite difficulties with dosing and monitoring.
Conclusions: The survey reveals varied treatment approaches to HT in CKD, highlighting key challenges like poor adherence and resistant HT. It emphasizes the need for personalized care, early detection, and integrated multidisciplinary management.
Metrics
References
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595-601. DOI: https://doi.org/10.1161/01.HYP.0000145180.38707.84
Obrador GT, Schultheiss UT, Kretzler M, Langham RG, Nangaku M, Pecoits-Filho R, et al. Genetic and environmental risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7(2):88-106. DOI: https://doi.org/10.1016/j.kisu.2017.07.004
Talukdar R, Ajayan R, Gupta S, Biswas S, Parveen M, Sadhukhan D, et al. Chronic Kidney Disease Prevalence in India: A Systematic Review and Meta-Analysis from Community-Based Representative Evidence Between 2011 to 2023. Nephrology (Carlton). 2025;30(1):e14420. DOI: https://doi.org/10.1111/nep.14420
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305. DOI: https://doi.org/10.1056/NEJMoa041031
Vondenhoff S, Schunk SJ, Noels H. Increased cardiovascular risk in patients with chronic kidney disease. Herz. 2024;49(2):95-104. DOI: https://doi.org/10.1007/s00059-024-05235-4
Chronic Kidney Disease Prognosis Consortium (CKD-PC), Matsushita K, van der Velde M. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81. DOI: https://doi.org/10.1016/S0140-6736(10)60674-5
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-87. DOI: https://doi.org/10.1016/j.kint.2020.11.003
American Heart Association (AHA)/American College of Cardiology (ACC) 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71:e13-5.
de Jong Y, van der Willik EM, Milders J, Yvette M, Rachael LM, Friedo WD. Person centred care provision and care planning in chronic kidney disease: which outcomes matter? A systematic review and thematic synthesis of qualitative studies. BMC Nephrol. 2021;22(1):309. DOI: https://doi.org/10.1186/s12882-021-02489-6
GBD 2019 Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories. Lancet. 2020;396(10258):1204-22.
Rajapurkar MM, John GT, Kirpalani AL, Georgi A, Sanjay KA, Alan FA, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. Clin J Am Soc Nephrol. 2012;7(9):1470-7. DOI: https://doi.org/10.1186/1471-2369-13-10
Ku E, Benjamin JL, Jenny W, Matthew RW. Hypertension in CKD: Core Curriculum 2019. Kidney Int. 2019;74(1):120-31. DOI: https://doi.org/10.1053/j.ajkd.2018.12.044
Williams B, Mancia G, Spiering W, Enrico AR, Michel A, Michel B, et al. 2023 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. DOI: https://doi.org/10.1093/eurheartj/ehy439
Calhoun DA, Daniel J, Stephen T, David CG, Timothy PM, Robert DT, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment. Hypertension. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-19. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.108.189141
Makani H, Sripal B, Kavit AD, Arpit S, Franz HM. Dual blockade of the renin–angiotensin system: A meta-analysis of randomized trials. BMJ. 2013;346:f360. DOI: https://doi.org/10.1136/bmj.f360
Downloads
Published
How to Cite
Issue
Section
